CompanyHeadlineTime (ET)
LTRNLantern Pharma Inc. (LTRN) Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors Transcript11/20 20:33
BFHBread Financial Announces Pricing of an Offering of Depositary Shares Representing Interests in Its Series A Preferred Stock11/20 20:33
AAAUGold Falls as Traders Weigh Fed's Next Move11/20 20:23
PGREParamount, Comcast and Netflix Submit Bids For Warner Bros. Discovery11/20 20:19
PODDInsulet Corporation (PODD) Analyst/Investor Day Transcript11/20 20:13
INTUIntuit Inc. (INTU) Q1 2026 Earnings Call Transcript11/20 20:13
ORCLOracle Names Stephen Rusckowski to the Board of Directors11/20 20:12
JJJ37 Capital Closes Third Tranche of Equity Financing11/20 20:06
Medicaid vs. CHIP: Key Differences in Children’s Healthcare Coverage11/20 20:05
Existing-Home Sales Rise Despite Government Shutdown11/20 20:05
NVDAThe Chip CEO Staring Down Nvidia and Talk of an AI Bubble11/20 20:02
KLICWhy Kulicke & Soffa Industries Stock Triumphed on Thursday11/20 20:01
VOOVanguard S&P 500 ETF Offers Lower Costs Than SPDR SPY -- But Should You Care?11/20 20:00
PSFEPaysafe Limited INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (PSFE)11/20 20:00
VISNovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward11/20 20:00
NEGXFNexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth11/20 19:55
MAYNFAustralia Blocks U.S.-Based Cosette's $387.2 Million Takeover of Mayne Pharma11/20 19:54
UGIUGI (UGI) Reports Q4 Loss, Misses Revenue Estimates11/20 19:51
EVGNEverGen Infrastructure Reports Q3 2025 Results11/20 19:51

Market News ×
Loading news…